Pelvic floor disorder. Stress incontinence (female) (male)
Conditions
Interventions
Intervention 1: Intervention group: They received magnet therapy and pelvic floor exercises. Intervention 2: Control group:They only received pelvic floor exercises.
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
21 Years to No maximum
Inclusion criteria
Inclusion criteria: Women 21 years and older with similar number of deliveries with stress urinary incontinence Body mass index in the range of 30-35 Lack of neurological diseases such as multiple sclerosis. Lack of sensory and motor disorders. Lack of mental illnesses (preventing proper communication and understanding) no musculoskeletal disorders. presence of urine leakage during coughing urine leakage of about 200-250 ml. incontinence questionnaire score Urine and quality of life should be at least 6 (normal is 21). Ability to perform pad test The patient should participate in the study voluntarily and by signing the consent form.
Exclusion criteria
Exclusion criteria: People with other types of urinary incontinence such as urgent urinary incontinence, functional urinary incontinence, mixed urinary incontinence. History of any heart failure and illness such as severe cardiac arrhythmia hypertension. Pacemaker and metal In the body Acute infection Malignancy Pregnancy or try for pregnancy Surgery to treat stress urinary incontinence. Vaginal bleeding History of pelvic surgery between 3-8 weeks ago History of pelvic radiation Having Pelvic ulcer or burn. History of medication for urinary incontinence in the past three months such as alpha-adrenergic, diuretic, serotonin, epinephrine. High blood sugar glucose 100mmol / lit
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The quality of life questionnaire,. Timepoint: Before the intervention and treatment of the eighth session and one month after the last treatment session. Method of measurement: I-QOL questionnaire.;Urinary incontinence intensity,. Timepoint: Before the intervention and treatment of the eighth session and one month after the last treatment session. Method of measurement: By determining the amount of urine absorbed in the pad.;Urinary incontinence frequency,. Timepoint: Before the intervention and treatment of the eighth session and one month after the last treatment session. Method of measurement: Using the patient self report.;Urine frequency,. Timepoint: Before the intervention and treatment of the eighth session and one month after the last treatment session. Method of measurement: Using the patient self report.;Delivery frequency,. Timepoint: Before the intervention and treatment of the eighth session and one month after the last treatment session. Method of measurement: Using the patient self report.;BMI. Timepoint: Before the intervention and treatment of the eighth session and one month after the last treatment session. Method of measurement: using BMI index. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactLeila Abbasi
Shiraz University of Medical Sciences
Outcome results
None listed